Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics (2014)
- Authors:
- USP affiliated authors: LAURETTI, GABRIELA ROCHA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.jpba.2013.11.032
- Subjects: PLASMA (HUMANO); CROMATOGRAFIA LÍQUIDA; ESPECTROMETRIA DE MASSAS; FARMACOCINÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Pharmaceutical and Biomedical Analysis
- ISSN: 0731-7085
- Volume/Número/Paginação/Ano: v. 90, p. 180\2013185, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MORAES, Natália Valadares de et al. Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, v. 90, p. 180\2013185, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2013.11.032. Acesso em: 16 fev. 2026. -
APA
Moraes, N. V. de, Lauretti, G. R., Filgueira, G. C. de O., Lopes, B. C. P., & Lanchote, V. L. (2014). Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, 90, 180\2013185. doi:10.1016/j.jpba.2013.11.032 -
NLM
Moraes NV de, Lauretti GR, Filgueira GC de O, Lopes BCP, Lanchote VL. Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2014 ; 90 180\2013185.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1016/j.jpba.2013.11.032 -
Vancouver
Moraes NV de, Lauretti GR, Filgueira GC de O, Lopes BCP, Lanchote VL. Analysis of rocuronium in human plasma by liquid chromatography–tandem mass spectrometry with application in clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2014 ; 90 180\2013185.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1016/j.jpba.2013.11.032 - In vivo activity of CYP2D6 and enantioselective tramadol clearance in patients with neuropathic pain
- Effects of type 1 and type 2 diabetes on the pharmacokinetics of tramadol enantiomers in patients with neuropathic pain phenotyped as cytochrome P450 2D6 extensive metabolizers
- Enantioselective analysis of unbound tramadol, O-desmethyltramadol and N-desmethyltramadol in plasma by ultrafiltration and LC-MS/MS: application to clinical pharmacokinetics
- Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain
- Transdermal racemic ketamine versus transdermal s(+)-ketamine as adjuvantsa for postoperative analgesia following orthopedic surgery under spinal anesthesia
- Transdermal racemic versus transdermal s(+)-ketamine as adjuvant for postoperative analgesia following orthopedic surgery
- The clinical and laboratorial evaluation of transdermal fentanyl, ketamine, clonidine, or their combination in chronic neuropathic pain
- Avaliação do efeito antinociceptivo e da resposta ao estresse da cetamina, clonidina, ou fentanil, aplicados por via transdérmica, no controle da dor
- Possíveis mecanismos de ação da estimulação elétrica nervosa transcutânea no controle da dor
- Clinical evaluation of epidural racemic bupivacaine, compared to a formulation containing 25% R(+)-, and 75% S(-)-bupivacaine
Informações sobre o DOI: 10.1016/j.jpba.2013.11.032 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
